STOCK TITAN

Enovis (ENOV) CFO awarded 47,974 RSUs as 3,167 shares withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enovis CORP senior vice president and CFO Phillip Benjamin (Ben) Berry received an equity grant of 47,974 shares of common stock through restricted stock units. These RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, aligning his compensation with long-term company performance.

In a separate transaction, 3,167 shares were withheld by the company at a price of $24.51 per share to cover tax obligations tied to the net settlement of restricted stock units, which the company states does not represent a sale by Berry. Following these transactions, he holds 158,596 shares of Enovis common stock directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BERRY PHILLIP BENJAMIN (BEN)

(Last) (First) (Middle)
2711 CENTERVILLE ROAD
SUITE 400

(Street)
WILMINGTON DE 19808

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/07/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 03/07/2026 F 3,167(1) D $24.51 110,622 D
Common stock, par value $0.001 03/09/2026 A 47,974(2) A $0.00 158,596 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.
2. This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
/s/ Brian P. Hanigan, attorney-in-fact 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Enovis (ENOV) report for CFO Phillip Benjamin Berry?

Enovis reported two transactions for CFO Phillip Benjamin (Ben) Berry. He received a grant of 47,974 restricted stock units and had 3,167 shares withheld by the company to cover tax obligations related to restricted stock unit settlement, with no open-market sale involved.

How many Enovis (ENOV) shares did the CFO receive in the latest equity award?

The CFO received an equity award of 47,974 shares in the form of restricted stock units. These RSUs are structured to vest over time, encouraging long-term alignment between his interests and Enovis shareholders as each installment vests on future anniversaries of the grant date.

How do the Enovis (ENOV) CFO’s new restricted stock units vest over time?

The CFO’s restricted stock unit award at Enovis vests in three equal annual installments. Vesting begins on the first anniversary of the grant date, then continues annually, meaning the full 47,974-share award will be delivered in three time-based tranches over three years.

Did the Enovis (ENOV) CFO sell any shares in these reported transactions?

No, the filing states there was no sale by the CFO. The 3,167-share disposition was specifically described as shares withheld by Enovis to satisfy tax withholding and remittance obligations related to restricted stock units, not an open-market or discretionary sale.

How many Enovis (ENOV) shares does the CFO hold after these transactions?

After the reported transactions, the CFO holds 158,596 Enovis common shares directly. This figure reflects his position following both the new restricted stock unit grant and the tax withholding share disposition, as disclosed in the ownership totals after each transaction entry.

What was the tax withholding transaction price in the Enovis (ENOV) Form 4?

The tax withholding transaction used a price of $24.51 per Enovis share. At that price, 3,167 shares were withheld by the company to cover tax obligations associated with the net settlement of the CFO’s restricted stock units, according to the Form 4 disclosure and footnote.
Enovis Corp

NYSE:ENOV

View ENOV Stock Overview

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.33B
56.29M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON